Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11
Open Access
- 10 October 2011
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 31 (23) , 2836-2848
Abstract
Mutations of p53 in cancer can result in a gain of function associated with tumour progression and metastasis. We show that inducible expression of several p53 ‘hotspot’ mutants promote a range of centrosome abnormalities, including centrosome amplification, increased centrosome size and loss of cohesion, which lead to mitotic defects and multinucleation. These mutant p53-expressing cells also show a change in morphology and enhanced invasive capabilities. Consequently, we sought for a means to specifically target the function of mutant p53 in cancer cells. This study has identified ANKRD11 as a key regulator of the oncogenic potential of mutant p53. Loss of ANKRD11 expression with p53 mutation defines breast cancer patients with poor prognosis. ANKRD11 alleviates the mitotic defects driven by mutant p53 and suppresses mutant p53-mediated mesenchymal-like transformation and invasion. Mechanistically, we show that ANKRD11 restores a native conformation to the mutant p53 protein and causes dissociation of the mutant p53–p63 complex. This represents the first evidence of an endogenous protein with the capacity to suppress the oncogenic properties of mutant p53.Keywords
This publication has 45 references indexed in Scilit:
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced MetastasisCell, 2009
- Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathwayMolecular Cancer, 2009
- The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugsCell Cycle, 2008
- An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutationsJournal of Clinical Investigation, 2007
- Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulationCancer Cell, 2006
- Regulation of Cdc42‐mediated morphological effects: a novel function for p53The EMBO Journal, 2002
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutantsProceedings of the National Academy of Sciences, 2002
- Rescuing the function of mutant p53Nature Reviews Cancer, 2001
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994